NewGenIvf Group Limited (NASDAQ:NIVF) Short Interest Update

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 654,534 shares, a growth of 631.2% from the June 15th total of 89,521 shares. Based on an average daily volume of 18,460,916 shares, the short-interest ratio is presently 0.0 days. Currently, 28.6% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on NIVF shares. Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Insider Buying and Selling

In related news, major shareholder Financial Lp Hrt purchased 45,847 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $2.97 per share, for a total transaction of $136,165.59. Following the completion of the purchase, the insider directly owned 37,295 shares in the company, valued at $110,766.15. This trade represents a -536.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 31.80% of the company’s stock.

NewGenIvf Group Stock Performance

NASDAQ NIVF traded up $0.09 during trading on Friday, reaching $1.40. 316,597 shares of the company’s stock were exchanged, compared to its average volume of 3,412,064. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. The business has a 50 day moving average price of $2.39 and a 200-day moving average price of $8.88. NewGenIvf Group has a fifty-two week low of $1.19 and a fifty-two week high of $624.60.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings data on Tuesday, March 31st. The company reported ($861.72) earnings per share (EPS) for the quarter. The firm had revenue of $1.42 million during the quarter. As a group, equities research analysts anticipate that NewGenIvf Group will post 14.22 earnings per share for the current year.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.